欧林生物 (688319)
Chengdu Olymvax Biopharmaceuticals Technology Co., Ltd.
K-Line Chart
No K-line data available
Company NameChengdu Olymvax Biopharmaceutical Co., Ltd.
Listing Date2021-06-08
Issue Price9.88RMB
Registered Capital40570.8910k RMB
Legal RepresentativeFan Shaowen
Registered AddressNo. 99 Tianxin Road, Chengdu High-Tech Zone, Sichuan Province
IndustryBiological Products
Main BusinessFocusing on the research and development, production, and sales of human vaccines
Company ProfileChengdu Olymvax Biopharmaceutical Co., Ltd. is a national high-tech enterprise specializing in the research and development, production, and sales of human vaccines, with a focus on innovative products. The company adheres to the business philosophy of 'Strengthening process management, committing to continuous improvement, and pursuing the highest quality,' aiming to become an 'internationally renowned and domestically leading' vaccine supplier. In terms of drug production facility construction and management, the company builds and manages its facilities in compliance with China's 2010 GMP standards while referencing standards from developed countries in Europe and America, laying a solid foundation for its products to enter the international market. In product development, the company implements a dual-drive strategy of 'innovative vaccine development + traditional vaccine upgrades' and a dual-wing approach of 'independent R&D + collaborative R&D.' Currently, the company has established a tiered product development structure, with two products on the market, several in clinical trial stages, and multiple others as R&D reserves.
Stock Details
1. Key Indicators
- Total Shares(W): 151306.51
- Circulating A-Shares(W): 149718.51
- Earnings Per Share(RMB): 0.36
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): -112811.60
- **Net Profit Attributable to Parent(W RMB) **: -112811.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- R&D, production, sales, and services of automobiles and their engines and components
3. Company Basic Information
- Company Name: Seres
- Listing Date:
- Industry:
- Address:
- Website:
- Company Profile: The company is a comprehensive automobile manufacturing enterprise integrating the R&D, manufacturing, sales, and services of automobiles, engines, and components.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Dongfeng Motor Group Co., Ltd. | National Team | 50000.00 | 33.05 |
| 2 | China Securities Finance Co., Ltd. | National Team | 5000.00 | 3.31 |
| 3 | Central Huijin Asset Management Co., Ltd. | National Team | 2500.00 | 1.65 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Foreign Legal Person | 2000.00 | 1.32 |
| 5 | China Asset Management Co., Ltd. | Public Fund | 1500.00 | 0.99 |
| 6 | E Fund Management Co., Ltd. | Public Fund | 1200.00 | 0.79 |
| 7 | China Merchants Fund Management Co., Ltd. | Public Fund | 1000.00 | 0.66 |
| 8 | Guotai Junan Securities Co., Ltd. | Brokerage | 800.00 | 0.53 |
| 9 | CITIC Securities Co., Ltd. | Brokerage | 600.00 | 0.40 |
| 10 | National Social Security Fund | National Team | 500.00 | 0.33 |
5. Concept Sectors
- Huawei Auto
- New Energy Vehicle
- Vehicle Networking
- Autonomous Driving
- Fuel Cell
- Hydrogen Energy
- Carbon Neutrality
- Intelligent Transportation
Remarks
- Data update date:
- Data source: Provided stock information